Gsk Share Discussion Threads

[eurofox] 11/3/2021 10:53

more likely selling to crystallize loses before the end of tax year

[netcurtains] 11/3/2021 10:48

FTSE deep in red now. Noting to do with drug companies, banks , uncle tom cobly.
its just sell buttons being hit - possibly brexit related and the total collapse of UK -German trade.

[montyhedge] 11/3/2021 10:35

If Astra falls below 7000p, then GSK will be 1225p.

[tradermichael] 11/3/2021 10:32

I see GSK being a leader in a combination vaccine, possibly this winter for over 65's in:
covid-19 (and variants) plus Seasonal influenza vaccine

And a second combined immunisation to include a (once only) pneumococcal vaccine

[tradermichael] 11/3/2021 10:26

Good point, but I can't imagine a global population that acquires herd immunity (certainly not in the short term). Add to that the ne'er sayers who are (for whatever reason) exempting themselves from protection, plus those who are not able to acquire immunity, and there will always be a critical need for this new drug.

[alphorn] 11/3/2021 10:20

I would add to the una post. If the vaccination program is successful then treatments required for those infected will substantially reduce.
This a cold look at the compound - not taking anything away from this good news.

[tradermichael] 11/3/2021 09:54

The game changer will be when a combined vaccine is rapidly developed and manufactured (to routinely include all variants of concern), and also when there is an oral form of vaccine (essential for the sceptics and the 'third' world populations).

I believe GSK and partners are targeting such approaches. In the meantime, its not unreasonable o expect the GSK share price to be underpinned.

[montyhedge] 11/3/2021 09:53

Holding well had a nice run up from 1202p. Astra getting hit, normally GSK follow Astra down.

[netcurtains] 11/3/2021 09:52

montyhedge: Can you let us know what the third step is?
Thanks.

[eurofox] 11/3/2021 09:36

VIR futures up 29% in US

[montyhedge] 11/3/2021 09:33

Yes traders always two steps ahead, so selling into a news rally.

[unastubbs] 11/3/2021 09:27

tm, i respect your views and thanks for giving a reason as to why this is a 'game changer'. i personally remain to be convinced, but i sincerely hope the market comes round to viewing this as you and others here do.

[spud] 11/3/2021 09:26

I suspect a large part of this news was already in the price. There's those that knows ya know....spud

[tradermichael] 11/3/2021 09:19

una - no other treatment exists that can reduce the likelihood of death from Covid-19 by 85% !!!!

Scientifically, this is a massive development in understanding mechanisms for treating this disease, which a year ago we did not even know how it was transmitted.

Not unreasonable to expect some decent movement in the share price, as it shows GSK is, indeed, ahead of the pack .... ;0)

[unastubbs] 11/3/2021 08:58

just two down ticks! that's fine. share price seems to bear out my reading of it. i have 2500 of these - i am very much invested here. but there's no point in putting on rose tinted glasses just because. GLA

[poikka] 11/3/2021 08:30

In case anyone missed it:

GSK is collaborating with several organisations on COVID-19 vaccines by providing access to our adjuvant technology. In addition to work with Sanofi, our collaboration with Medicago on an adjuvanted, protein-based vaccine candidate is now in late-stage clinical trials. An earlier stage collaboration with SK Bioscience is also ongoing, with funding from CEPI and Bill and Melinda Gates Foundation, to develop differentiated, affordable COVID-19 vaccines for supply globally through the COVAX facility. The use of an adjuvant can be of particular importance in a pandemic since it may reduce the amount of vaccine protein required per dose, allowing more vaccine doses to be produced, contributing to protecting more people.



GSK is also working with mRNA specialist, CureVac, to jointly develop next generation, multi-valent mRNA vaccines for COVID-19 with the potential to address multiple emerging variants in one vaccine. GSK will also support manufacturing of up to 100m doses of CureVac's first generation COVID-19 vaccine, if approved.

[poikka] 11/3/2021 08:29

The drop could reflect concerns (if that's the right word) that GSK could bid for VIR.

[eurofox] 11/3/2021 08:26

me also at 1254

[netcurtains] 11/3/2021 08:16

I bought a few 12.53p

[netcurtains] 11/3/2021 08:12

Perhaps dont look a gift horse in the mouth.
Pehaps time to top up.
😊

[spyder] 11/3/2021 08:11

If this was some spivy US stock called GameGlaxoStop the share price would have doubled to a market cap of $200m!

[spyder] 11/3/2021 08:09

Wow - who would have predicted that share price reaction!
“Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalisation or death.
· Vir and GSK plan to immediately seek Emergency Use Authorization in the US and authorisations in other countries.
· Additional new in vitro studies indicate VIR-7831 maintains activity against major circulating COVID-19 variants.”

[amt] 11/3/2021 08:06

Yes it is a Game changer but the news has to cross the desks of the major investors before they realise it.